Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated July 18, 2026, titled "Alembic Pharmaceuticals Limited's Partner NATCO Pharma Limited receives USFDA Tentative Approval for Olaparib Tablets, 100 mg and 150 mg".
Alembic Pharmaceuticals Limited Press Release Jul 18 2026
Earlier from Alembic Pharmaceuticals
- Alembic Pharmaceuticals Limited Press Release Jun 26 2026
- Alembic Pharmaceuticals Limited Press Release Jun 19 2026
- Alembic Pharmaceuticals Limited Press Release Jun 12 2026
- Alembic Pharmaceuticals Limited Press Release Jun 11 2026